FDA's Overreach on Compounded Peptides BPC 157 & The Gut Brain Axis: A Practitioner's Definitive Review of the Evidence BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved drugs with Peptides are often discussed as one big category but they are not all the same. Some peptides are FDA approved medications with clear indications and safety data. Many others being marketed for Peptide Therapy for Inflammation: A New Solution Peptide Therapy 101: Can BPC 157 & Thymosin Beta 4 Accelerate Ortho Recovery?